AI-generated summary
The authors retrospectively reviewed 25 cancer patients with refractory oral mucositis treated with a high-power intraoral laser for pain relief. They report immediate pain reduction after 94% of 79 sessions, with complete relief in 35% of sessions, and benefit lasting a mean of 6.0 days. The study had no control group and the authors describe the results as preliminary.
- Participants
- 25
- Who or what was studied
- 25 cancer patients with refractory chemotherapy- or radiotherapy-induced oral mucositis (16 chemotherapy, 9 radiotherapy)
- Limits stated in the abstract
- The study is retrospective, has a small sample, and includes no control group, so the pain reductions cannot be attributed to the laser alone.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Oral mucositis, Photobiomodulation therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.